Equity Research Database

Institutional Investment Pitches

Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.

Home Letters Funds Account

Rodrigo Benedetti's investment thesis on RxSight, Inc. ($RXST) — Q2 2025 | Buyside Digest

All Pitches

View Letter Analysis

$RXSTNASDAQRxSight, Inc.

BULL

Rodrigo Benedetti—RXST

Fund Letter

Q2 2025

Published June 30, 2025

View Fund Profile

$5.99USD

-6.1% vs last month

$13.05Pitched

-54.1% since pitch

Market Cap$247.8M

P/E (TTM)N/A

52-Wk RangeN/A

Div. YieldN/A

Technical Chart

From the Fund Letter

The manager delivered strong Q2 performance despite significant volatility, with the SPX rallying 27% from lows in the most volatile quarter since 2022. Trump's initial tariff...

— Rodrigo

BSD Research Exclusive

Unlock Full Institutional Investment Theses

Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.

6,000+ Institutional Pitches

Proprietary AI Analysis

100 Letter Unlocks/Cycle

SUBSCRIBE TO BSD RESEARCH ($55/MO)Compare All Plans

Already a Research or Pro subscriber? Sign In

◆ Keep Reading

What other investors think about $RXST, and what else Rodrigo Benedetti is buying.

Other pitches on $RXST

Other investors who've written on RxSight, Inc.

No other institutional pitches found for this ticker yet.

View all $RXST pitches →